Date: Wednesday, April 20, 2016
Time: 9:00 am - 2:00 pm (BST)
Chesterford Research Park, CB10 1XL Little Chesterford, United Kingdom
Today’s scientists are under significant time pressure to accelerate their compound from discovery to the clinic. Such pressure can often lead research organizations to adopt short-term thinking and overlook the downstream realities of drug development. Addressing issues early and comprehensively in the development life-cycle can result in fewer problems down the line such as escalating timelines, costs and regulatory issues. It is important to leverage the skills and experience of experts and connect the dots between competencies to optimize the development pathway and enable drug candidates to reach their true potential.
This event will focus on a number of key considerations for transitioning a molecule from discovery to Phase I readiness including API and formulation development, clinical study design, and regulatory requirements.